Fertility drugs and cancer risk: what you need to know

The journey to motherhood is not always simple, and for many women, fertility treatments are an important part of that path. It's natural, however, to have concerns about the safety of these medications, especially regarding the potential risk of cancer. A new guide published by American Society for Reproductive Medicine (ASRM) Review what science has to say about it. I will explain here what this means for those considering treatment, using simple and clear language.

What are fertility drugs?

Before we delve into the research, it's helpful to understand what these medications do. Generally, they stimulate ovulation, increasing the chances of conception. Here are the main types:

Clomiphene citrate: It stimulates the body to release hormones that promote the growth and release of eggs.

Gonadotropins: Hormones that act directly on the ovaries to produce and mature eggs.

These medications are used in treatments such as artificial insemination and in vitro fertilization (IVF), and they can be fundamental to the success of the process.

What conclusions did the ASRM draw regarding cancer risk?

The new ASRM guide is based on an analysis of studies spanning decades.

Below are the main points for each type of cancer analyzed:

1. Breast Cancer

Conclusion: There is insufficient evidence to suggest that the use of fertility drugs increases the risk of breast cancer.

What this means: while increased hormone levels may worry some patients, research does not show a direct link between fertility treatments and breast cancer.

2. Colon and Cervical Cancer

Conclusion: There is no proven link between the use of these medications and an increased risk of these types of cancer.

What does this mean? It's a relief to know that these treatments don't increase the risk of these specific types of cancer.

3. Endometrial Cancer (Uterus)

Conclusion: There is no direct evidence that fertility drugs increase the risk, but some cases of infertility are related to a naturally higher risk.

What does this mean? In some patients, the cause of infertility may, by itself, increase the risk of endometrial cancer, regardless of medication use.

4. Ovarian Cancer

Conclusion: Some studies suggest a slight increase in risk, but it is still unclear whether this is due to the medications or to factors such as endometriosis and infertility itself.

What does this mean? This is one of the most delicate points, but it's important to remember that the increased risk is very small and usually related to pre-existing conditions.

5. Thyroid Cancer

Conclusion: There is some indication of increased risk with prolonged use of clomiphene, but the data are still inconclusive.

What does this mean? Patients should monitor their thyroid health with their doctors, especially if they use clomiphene for extended periods.

So, what is the real risk?

Often, infertility itself is linked to a slightly higher risk of certain types of cancer, regardless of medication use. The decision to begin fertility treatment should always take into account each person's individual health profile, and this is where the doctor's role comes in, guiding them towards the best course of action.

What you need to know to make a safe decision.

When it comes to fertility, every choice should be well-informed. This guide shows us that, for most patients, the risks are very low and that medical monitoring makes all the difference.

Remember: The decision regarding fertility treatment is personal and unique. If you have any questions, please talk to me or your trusted medical team. I will be here to guide you and clarify any concerns you may have on your journey to motherhood.

Schedule an Appointment – Click Here

Tags: ASRM fertility, cervical cancer, endometrial cancer, breast cancer and fertility, ovarian cancer, thyroid cancer, cancer and fertility, Clomiphene citrate, fertility and cancer risk, Gonadotropins, fertility drugs, risks of fertility drugs, reproductive health, fertility treatment, fertility treatments

Dr. Danielle Miyague

mãos de gestante segurando uma imagem de ultrassom

Tetralogy of Fallot: what does this diagnosis mean during pregnancy?

Receiving the news that there is a heart defect in the baby during pregnancy often generates many doubts and insecurities. Among the congenital heart defects that can be identified prenatally is... Fallot's Tetralogy, a heart condition that is relatively well-known in medicine, but poorly understood by the general public.

In this article, I explain What is Tetralogy of Fallot, how can it be identified during pregnancy, and why is prenatal diagnosis so important for planning the baby's care?.

The goal is to transform a complex medical term into understandable information, without alarmism and always based on evidence.

Agenesis of the Corpus Callosum: What does this diagnosis mean during pregnancy?

Receiving a different diagnosis during pregnancy often generates many doubts, insecurities, and, naturally, fear. When the term involved is agenesis of the corpus callosum, However, this feeling can be even more intense, after all, we are talking about the development of the baby's brain.

This article was written to explain, in a way clear, responsible and evidence-based, What is agenesis of the corpus callosum, how can it be identified during pregnancy, what are the possible outcomes, and, most importantly, What is the role of fetal medicine in this context?.

If you have received this diagnosis or are investigating this possibility, know this from the start: Quality information helps transform anxiety into care and planning..

Obstetra e médico fetal analisam o ultrassom em conjunto para oferecer cuidado integral à gestante e ao bebê.

The relationship between the Obstetrician and the Fetal Medicine specialist: two areas that complement each other in caring for the same life.

When a pregnant woman arrives at the doctor's office for the first time, she brings with her a mixture of joy, expectation, and worry. And it is precisely at this beginning that a common question arises: What is the difference between an obstetrician and a doctor specializing in fetal medicine?

They both participate in the same pregnancy, care for the same baby, and walk together, but each with a very specific role.

It is about this partnership that I want to talk here. To explain how we complement each other, why we work side by side, and how this relationship ensures greater safety, diagnostic accuracy, and peace of mind for the family.

Ultrassom ilustrado de bebê no útero, representando o diagnóstico e acompanhamento de tumores fetais com esperança e cuidado.

Fetal tumors: when diagnosis is not a death sentence.

Receiving the news of a "tumor in the baby" while still in the womb naturally evokes fear and insecurity. It's a powerful word, loaded with meaning and often immediately associated with something malignant.

But it's not always like that.
In fetal medicine, many tumors diagnosed during pregnancy are benign and can be safely monitored until birth.

In this article, I want to clearly explain what fetal tumors are, where they usually appear, what risks are involved, and, most importantly, how we can best care for them with responsibility, planning, and hope.